This site is intended for Healthcare professionals only.

Everest Organics enters US market

Everest Organics enters US market

New Delhi: Pharma company Everest Organics said it has entered the US market with the initial supply order for Omiprazole API in the country.

Omiprazole API is a medication used in the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger Ellison syndrome.

The company has tied up with a US-based pharma firm and the same has resulted in the first trial order for the company, Everest Organics said in a BSE filing.

“We see excellent opportunity to drive increased sales and profitability by growing our sales to regulated market over the period of two to three years,” Everest Organics MD Sri Kakarlapudi Srihari Raju said.

The entry into the US market is a significant step forward in strengthening the company’s presence in the developed market, he added.

READ  Aurobindo Pharma shares fall 5 percent on reports of USFDA observations


Source: PTI
0 comment(s) on Everest Organics enters US market

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted